Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07368335

Efficacy and Safety of a Novel ERCP Robot in the Treatment of Common Bile Duct Stone

Efficacy and Safety of Endoscopic Treatment in Common Bile Duct Stone Based on the Electronic Endoscopic Surgery System: A Prospective, Multicenter, Randomized Controlled Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Conventional endoscopic retrograde cholangiopancreatography (ERCP) is performed under fluoroscopic guidance, exposing endoscopists to ionizing radiation and posing risks of work-related musculoskeletal injury. Robotic-assisted ERCP may mitigate these occupational hazards and potentially enhance procedural precision and stability. However, robust clinical evidence regarding its performance and safety remains limited. This prospective, multicenter, randomized controlled non-inferiority trial is designed to evaluate the efficacy and safety of an ERCP robotic system (Electronic Endoscopic Surgery System) developed by Shanghai Aohua Photoelectricity Endoscope Co., Ltd. for common bile duct stone removal. A total of at least 200 subjects will be recruited and randomized 1:1 to either the experimental group or the control group. The experimental group will undergo robotic-assisted ERCP lithotomy using the aforementioned system, while the control group will receive conventional ERCP lithotomy using a standard duodenoscope.

Conditions

Interventions

TypeNameDescription
DEVICERobotic-assisted ERCPThis group will receive endoscopic common bile duct lithotomy using the Electronic Endoscopic Surgery System produced by Shanghai Aohua Endoscopy Co., Ltd.
DEVICEConventional ERCPThis group will undergo conventional endoscopic common bile duct lithotomy with a regular electronic duodenoscope.

Timeline

Start date
2025-12-24
Primary completion
2026-12-01
Completion
2026-12-30
First posted
2026-01-26
Last updated
2026-01-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07368335. Inclusion in this directory is not an endorsement.